At Maryland Lifesciences’ 2020 Bio Innovation Conference, American Gene Technologies (AGT) took center stage. AGT was the virtual event’s diamond sponsor, AGT’s CEO and Founder Jeff Galvin kicked off the event with opening remarks and then hosted several panel discussions, including “Expanding Progress and Opportunities in Gene and Cell Therapy,” which was a highlight of the conference’s second day.
UMB Startup Breethe Acquired by Abiomed to Commercialize Wearable Artificial Lung System The Deal Marks Another Successful Exit Supported by UM Ventures May 26, 2020 Breethe, a company built on [….]
BioHealth Capital Region Startups Raised More Than $739M in 2019 These 15 Biohealth Startups had a Banner Year, Setting Themselves Up for Success in 2020 The startup ecosystem in the [….]
Success Breeds Success: How A $250M Acquisition Catalyzed Baltimore’s MedTech Ecosystem November 12, 2019 One company gets absorbed into a larger brand and a host of companies flower as a result. [….]